Increasing sensitivity to DNA damage is a potential driver for human ovarian cancer

Oncotarget. 2016 Aug 2;7(31):49710-49721. doi: 10.18632/oncotarget.10436.

Abstract

Ovarian cancer is one of the most common cancers among women, accounting for more deaths than any other gynecological diseases. However, the survival rate for ovarian cancer has not essentially improved over the past thirty years. Thus, to understand the molecular mechanism of ovarian tumorigenesis is important for optimizing the early diagnosis and treating this disease. In this study, we observed obvious DNA lesions, especially DNA double strand breaks (DSBs) accompanying cell cycle checkpoint activation, in the human epithelial ovarian cancer samples, which could be due to the impaired DNA response machinery. Following this line, we found that these DNA damage response-deficient primary cancer cells were hypersensitive to DNA damage and lost their ability to repair the DNA breaks, leading to genomic instability. Of note, three key DNA damage response factors, RNF8, Ku70, and FEN1 exhibited dramatically decreased expression level, implying the dysfunctional DNA repair pathways. Re-expression of wild type RNF8, Ku70, or FEN1 in these cells restored the DNA lesions and also partially rescued the cells from death. Our current study therefore proposes that accumulated DNA lesions might be a potential driver of ovarian cancer and the impaired DNA damage responders could be the targets for clinical treatment.

Keywords: DNA damage; DNA repair; genomic instability; ovarian cancer.

MeSH terms

  • Adult
  • Biomarkers, Tumor / metabolism
  • Cell Cycle
  • Comet Assay
  • DNA Breaks, Double-Stranded
  • DNA Damage*
  • DNA Repair
  • DNA-Binding Proteins / metabolism
  • Female
  • Flap Endonucleases / metabolism
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Ku Autoantigen / metabolism
  • Middle Aged
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / pathology*
  • Ubiquitin-Protein Ligases

Substances

  • Biomarkers, Tumor
  • DNA-Binding Proteins
  • RNF8 protein, human
  • Ubiquitin-Protein Ligases
  • Flap Endonucleases
  • FEN1 protein, human
  • Ku Autoantigen